JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M301840200 on May 19, 2003

J. Biol. Chem., Vol. 278, Issue 30, 27644-27651, July 25, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/30/27644    most recent
M301840200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Javanbakht, H.
Right arrow Articles by Kleiman, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Javanbakht, H.
Right arrow Articles by Kleiman, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Interaction between HIV-1 Gag and Human Lysyl-tRNA Synthetase during Viral Assembly*

Hassan Javanbakht {ddagger} §, Rabih Halwani {ddagger} §, Shan Cen {ddagger}, Jenan Saadatmand {ddagger} §, Karin Musier-Forsyth ¶, Heinrich Gottlinger || and Lawrence Kleiman {ddagger} § ** {ddagger}{ddagger}

From the Lady Davis Institute for Medical Research and {ddagger}McGill AIDS Center, Jewish General Hospital, §Departments of Medicine and **Microbiology & Immunology, McGill University, Montreal, Quebec H3T 1E2, Canada, Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, and ||Department of Cancer, Immunology and AIDS, Dana Farber Cancer Institute, Boston, Massachusetts 02115

Human lysyl-tRNA synthetase (LysRS) is a tRNA-binding protein that is selectively packaged into HIV-1 along with its cognate tRNALys isoacceptors. Evidence exists that Gag alone is sufficient for the incorporation of LysRS into virions. Herein, using both in vitro and in vivo methods, we begin to map regions in Gag and LysRS that are required for this interaction. In vitro reactions between wild-type and truncated HIV-1 Gag and human LysRS were monitored using GST-tagged molecules and glutathione-agarose chromatography. Gag/LysRS interaction in vivo was detected in 293FT cells cotransfected with plasmids coding for wild-type or mutant HIV-1 Gag and LysRS, either by monitoring Gag·LysRS complexes immunoprecipitated from cell lysate with anti-LysRS or by measuring the ability of LysRS to be packaged into budded Gag viral-like particles. Based on these studies, we conclude that the Gag/LysRS interaction depends upon Gag sequences within the C-terminal domain of capsid (the last 54 amino acids) and amino acids 208–259 of LysRS. The latter domain includes the class II aminoacyl-tRNA synthetase consensus sequence known as motif 1. Both regions have been implicated in homodimerization of capsid and LysRS, respectively. Sequences falling outside these amino acid stretches can be deleted from either molecule without affecting the Gag/LysRS interaction, further supporting the observation that LysRS is incorporated into Gag viral-like particles independent of its ability to bind tRNALys.


Received for publication, February 20, 2003 , and in revised form, April 28, 2003.

* This work was supported in part by grants from the Canadian Institutes for Health Research and the Canadian Foundation for AIDS Research. This work was performed by H. Javanbakht in partial fulfillment of the Ph.D. degree at McGill University, Montreal, Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger}{ddagger} To whom correspondence should be addressed: Lady Davis Institute for Medical Research-Jewish General Hospital, 3755 Cote St. Catherine Rd., Montreal, Quebec H3T 1E2, Canada. Tel.: 514-340-8260; Fax: 514-340-7502; E-mail: lawrence.kleiman{at}mcgill.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. J. Kovaleski, R. Kennedy, A. Khorchid, L. Kleiman, H. Matsuo, and K. Musier-Forsyth
Critical Role of Helix 4 of HIV-1 Capsid C-terminal Domain in Interactions with Human Lysyl-tRNA Synthetase
J. Biol. Chem., November 2, 2007; 282(44): 32274 - 32279.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Palmer, R. Kirkman, B. R. Kosloff, P. G. Eipers, and C. D. Morrow
tRNA Isoacceptor Preference prior to Retrovirus Gag-Pol Junction Links Primer Selection and Viral Translation
J. Virol., May 1, 2007; 81(9): 4397 - 4404.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-F. Chou and C. R. Wagner
Lysyl-tRNA Synthetase-generated Lysyl-Adenylate Is a Substrate for Histidine Triad Nucleotide Binding Proteins
J. Biol. Chem., February 16, 2007; 282(7): 4719 - 4727.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Kaminska, V. Shalak, M. Francin, and M. Mirande
Viral Hijacking of Mitochondrial Lysyl-tRNA Synthetase
J. Virol., January 1, 2007; 81(1): 68 - 73.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. McCulley and C. D. Morrow
Complementation of Human Immunodeficiency Virus Type 1 Replication by Intracellular Selection of Escherichia coli Formula Supplied in trans
J. Virol., October 1, 2006; 80(19): 9641 - 9650.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Kovaleski, R. Kennedy, M. K. Hong, S. A. Datta, L. Kleiman, A. Rein, and K. Musier-Forsyth
In Vitro Characterization of the Interaction between HIV-1 Gag and Human Lysyl-tRNA Synthetase
J. Biol. Chem., July 14, 2006; 281(28): 19449 - 19456.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. J. Kelly and C. D. Morrow
Structural Elements of the tRNA T{Psi}C Loop Critical for Nucleocytoplasmic Transport Are Important for Human Immunodeficiency Virus Type 1 Primer Selection
J. Virol., May 15, 2005; 79(10): 6532 - 6539.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. G. Park, H. J. Kim, Y. H. Min, E.-C. Choi, Y. K. Shin, B.-J. Park, S. W. Lee, and S. Kim
From The Cover: Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response
PNAS, May 3, 2005; 102(18): 6356 - 6361.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. E. M. Abbink, N. Beerens, and B. Berkhout
Forced Selection of a Human Immunodeficiency Virus Type 1 Variant That Uses a Non-Self tRNA Primer for Reverse Transcription: Involvement of Viral RNA Sequences and the Reverse Transcriptase Enzyme
J. Virol., October 1, 2004; 78(19): 10706 - 10714.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. T. Miller, A. Khvorova, S. A. Scaringe, and S. F. J. Le Grice
Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes
Nucleic Acids Res., September 1, 2004; 32(15): 4687 - 4695.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Halwani, S. Cen, H. Javanbakht, J. Saadatmand, S. Kim, K. Shiba, and L. Kleiman
Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly
J. Virol., July 15, 2004; 78(14): 7553 - 7564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.